Wrapping up congress season
Marie Suard Marie Suard

Wrapping up congress season

As we wrap up an incredible congress season, we reflect on our fantastic journey across Europe. From Prague to Rome, we showcased our Histolog Scanner and connected with bright minds in the medical field.

Read More
Distributor training at Orsi Academy
Marie Suard Marie Suard

Distributor training at Orsi Academy

We've spent three days in Belgium with our distributors from across Europe, immersing ourselves in the integration of the Histolog Scanner into clinical workflows. During our time together, we delved into image analysis, device utilization, clinical evidence, and sales strategies through interactive workshops.

Read More
SamanTree Medical Appoints New Chief Executive Officer
Marie Suard Marie Suard

SamanTree Medical Appoints New Chief Executive Officer

Olivier Delporte joins SamanTree Medical with a proven track record of leadership in the medical technology industry. With over 22 years of experience driving growth and innovation of fast-growing companies across various therapeutic areas, Olivier is poised to lead the company towards new heights of success.

Read More
Distribution network set up
Marie Suard Marie Suard

Distribution network set up

SamanTree Medical, a medical technology company driven to support clinicians with their intraoperative decisions and improve cancer surgery outcomes, is pleased to announce the formation of a distribution network to expand the availability of its Histolog Scanner in Europe. The network will cover Spain, Portugal, Italy, Nordics, UK, Greece, Romania, Egypt, and BeNeLux.

Read More
Exciting clinical data in Prostate Cancer
Marie Suard Marie Suard

Exciting clinical data in Prostate Cancer

LAUSANNE, Switzerland, SamanTree Medical, a medical technology company driven to support clinicians with their intraoperative decisions and improve cancer surgery outcomes, announced today the publication of clinical data in prostate cancer, expanding the potential clinical utility of its proprietary medical imaging platform, the Histolog Scanner.

Read More
Reduction of re-operation rate in Breast Cancer
Marie Suard Marie Suard

Reduction of re-operation rate in Breast Cancer

SamanTree Medical, a medical technology company driven to support clinicians with their intraoperative decisions and improve cancer surgery outcomes, announced today the publication of clinical data unraveling the potential of its proprietary medical imaging platform, the Histolog® Scanner.

Read More
New study in skin cancer
Marie Suard Marie Suard

New study in skin cancer

SamanTree Medical, a medical technology company dedicated to supporting clinicians in making better intraoperative decisions and improving outcomes in cancer surgery, has announced the release of clinical data demonstrating the potential of its Histolog® Scanner in Mohs surgery.

Read More
Guiding clinicians is our mission
Marie Suard Marie Suard

Guiding clinicians is our mission

The accuracy of the information provided to clinicians is a game changer for their intraoperative practice, and we are only at the beginning of understanding the full potential of Histolog® images. SamanTree Medical is actively developing training materials and advanced image analysis tools to fully exploit this potential.

Read More
Strengthening of senior leadership team
Marie Suard Marie Suard

Strengthening of senior leadership team

SamanTree Medical, committed to improving cancer surgery outcomes, is building-out its senior leadership team by welcoming Dr Oleg Svanidze as Chief Medical Officer and Mr Cédric Trabucatti as Vice President Sales & Marketing.

Read More
Utilization of the Histolog® Scanner intraoperatively, clinical and economic perspectives
Marie Suard Marie Suard

Utilization of the Histolog® Scanner intraoperatively, clinical and economic perspectives

In November 2020, a non-palpable lesion in the right breast of a 63-year-old woman was detected during standard mammography screening. Suspicious microcalcifications were located at the 9 o’clock position, suspected ductal carcinoma in situ (DCIS), BIRADS IV (Fig. 1). Vacuum suction core biopsy confirmed the presence of poorly differentiated DCIS with associated microcalcifications.

Read More